News und Analysen
Pfizer Just Reassured Investors, but Is the Stock a Buy?
Amid a fall season characterized by restive shareholders seeking an activist bid to unseat senior management and change the trajectory of the company, Pfizer (NYSE: PFE) is communicating that
Should You Buy Vertex Pharmaceuticals on the Dip Before Potentially Enormous News in January 2025?
Vertex Pharmaceuticals (NASDAQ: VRTX) was on track to become one of this year's biotech winners, with the shares climbing 27% from January through a peak in November. The company, the global leader
3 Fantastic Stocks That Could Enjoy a Santa Claus Rally
Santa Claus will soon be on his way delivering presents to kids around the world. But could the jolly gift-giver bring something for investors, too? So-called "Santa Claus rallies" can occur near
Pfizer Could Soar to $36 Per Share, According to a Wall Street Analyst. Is It a Buy at Around $26?
Shares of Pfizer (NYSE: PFE) recently marched higher in response to a dividend payout raise and a forward-looking presentation. Management confirmed the annual revenue and earnings outlook it
2 Top Dividend Stocks to Buy and Hold Through 2025 and Beyond
What will be the hottest investing trend on Wall Street next year? Maybe artificial intelligence will keep up its momentum, or perhaps interest in weight loss-focused pharmaceutical companies will
New Survey Offers Important Insights into How Medicare Advantage Beneficiaries Use and Value Their Supplemental Benefits
A recent study conducted by Humana Healthcare Research, with strategic input from researchers at the University of Pennsylvania, reveals key insights into how Medicare Advantage beneficiaries
Less Paperwork, More Connected Care: Humana and Epic Advance Data Sharing
Humana Inc. [NYSE: HUM] today announced the broad activation of Epic’s Coverage Finder and Digital Insurance Card Exchange capabilities for its Medicare Advantage membership – marking a significant
Humana Partners to Expand Mental Health Education for Louisville’s Next Generation
Following World Mental Health Day, the Humana Foundation – the philanthropic arm of Humana Inc. for the past 44 years – along with Jewish Heritage Fund and the University of Louisville’s Christina
Humana’s 2026 Medicare Advantage Plans Prioritize Simplicity, Stability and Quality Care for Beneficiaries
Humana Inc. (NYSE: HUM), a leading health and well-being company, today announced its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2026. During the Medicare Annual Election
New Research in a New England Journal of Medicine Publication Finds Patients of Value-Based Care Organizations Have More Frequent and Consistent Primary Care Visits
A new study published in The New England Journal of Medicine Catalyst, conducted by the Humana Healthcare Research team and Massachusetts General Hospital Attending Physician Dr. Suhas Gondi, who
Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula
Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced positive topline results from an ongoing Phase 3 clinical trial cohort evaluating the safety
Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19
Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application
Humana Announces New Agreements to Expand Specialized Care Programs for Patients Living with Musculoskeletal Conditions
Leading health and well-being company Humana Inc. (NYSE: HUM) today announced new strategic, individual value-based care partnerships with Vori Health and HOPCo, in addition to the company’s
Humana Earns 2025 Great Place to Work Certification™ and PEOPLE Companies That Care® Recognition
Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, has been named a Certified™ Great Place To Work® for the fourth consecutive year and has earned a place on
Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union
Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has
Humana Accelerates Efforts to Eliminate Prior Authorization Requirements to Ensure a Faster, More Seamless Process
Humana Inc., a leading health and well-being company, today announced accelerated efforts to approve care requests as quickly as possible and reduce the administrative burden for physicians
Agilent to Announce Third-Quarter Fiscal Year 2025 Financial Results on Aug. 27
Following an announcement earlier this week, Agilent Technologies Inc. (NYSE: A) confirms it will release financial results for the third quarter of fiscal year 2025 after the stock market closes
Humana Simplifies Access to Coverage and Care Information
Humana Inc. [NYSE: HUM] announced today its latest collaboration with healthcare software company Epic, becoming the first health insurer to integrate health plan information directly into the
Agilent Announces CFO Transition
Agilent Technologies Inc. (NYSE: A) today announced that effective July 31, Senior Vice President and Chief Financial Officer Bob McMahon will step down from his role as he relocates to the East
XTANDI® Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence
Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced positive topline results from the overall survival (OS) analysis from the
Humana Foundation Responds to Central Texas Flood Tragedy with $500,000 in Recovery Support
The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM), announced today a $500,000 donation to aid recovery efforts in Central Texas following the tragic flooding that struck over the
Humana Launches Medicaid Plan in Virginia
Humana Healthy Horizons is now a Medicaid plan option for Virginians covered by Virginia Cardinal Care.
“At Humana, we put our members’ health first, and we are committed to improving the
Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI™ in Hemophilia A or B with Inhibitors
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 BASIS study (NCT03938792) evaluating HYMPAVZI™ (marstacimab) for adults and adolescents living with hemophilia A or
Pfizer Declares Third-Quarter 2025 Dividend
Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 third-quarter 2025 dividend on the company’s common stock, payable September 2, 2025, to holders of the Common
Pfizer Invites Public to View and Listen to Webcast of August 5 Conference Call with Analysts
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EDT on Tuesday, August 5, 2025. The